Director
Baxalta Innovations GmbH, Takeda group
Alfred Weber, PhD, is now working for more than 30 years with the pharmaceutical industry (Immuno, Baxter, Baxalta, Shire and now Baxalta Innovations GmbH, part of Takeda), focused on the analytical support for the development of plasma-derived and recombinant coagulation factors and inhibitors. Thus, he provided analytics and contributed to the development of the plasma-derived protein C concentrate CEPROTIN, the recombinant von Willebrand factor and the PEGylated recombinant factor VIII.
Tuesday, July 12, 2022
6:30 PM – 7:30 PM